Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

p16 Positive Histologically Bland Squamous Metaplasia of the Cervix: What does It Signify?

Goyal A, Ellenson LH, Pirog EC.

Am J Surg Pathol. 2019 Sep 6. doi: 10.1097/PAS.0000000000001364. [Epub ahead of print]

PMID:
31498174
2.

Expression of the Receptor for Hyaluronic Acid-Mediated Motility (RHAMM) in Endometrial Cancer is Associated With Adverse Histologic Parameters and Tumor Progression.

Schatz-Siemers N, Chen YT, Chen Z, Wang D, Ellenson LH, Du YN.

Appl Immunohistochem Mol Morphol. 2019 Mar 26. doi: 10.1097/PAI.0000000000000763. [Epub ahead of print]

PMID:
30920393
3.

Molecular Genetics of Endometrial Carcinoma.

Bell DW, Ellenson LH.

Annu Rev Pathol. 2019 Jan 24;14:339-367. doi: 10.1146/annurev-pathol-020117-043609. Epub 2018 Oct 17.

PMID:
30332563
4.

The uterine epithelial loss of Pten is inefficient to induce endometrial cancer with intact stromal Pten.

Liang X, Daikoku T, Terakawa J, Ogawa Y, Joshi AR, Ellenson LH, Sun X, Dey SK.

PLoS Genet. 2018 Aug 24;14(8):e1007630. doi: 10.1371/journal.pgen.1007630. eCollection 2018 Aug.

5.

Letter From the Editor.

Ellenson LH.

Int J Gynecol Pathol. 2017 Jan;36(1):1. doi: 10.1097/PGP.0000000000000379. No abstract available.

PMID:
29140255
6.

Stem Cell Pathology.

Fu DJ, Miller AD, Southard TL, Flesken-Nikitin A, Ellenson LH, Nikitin AY.

Annu Rev Pathol. 2018 Jan 24;13:71-92. doi: 10.1146/annurev-pathol-020117-043935. Epub 2017 Oct 20. Review.

7.

Despite Diagnostic Morphology, Many Mixed Endometrial Carcinomas Show Unexpected Immunohistochemical Staining Patterns.

Matrai CE, Pirog EC, Ellenson LH.

Int J Gynecol Pathol. 2018 Sep;37(5):405-413. doi: 10.1097/PGP.0000000000000443.

PMID:
29019871
8.

LEF1 is preferentially expressed in the tubal-peritoneal junctions and is a reliable marker of tubal intraepithelial lesions.

Schmoeckel E, Odai-Afotey AA, Schleißheimer M, Rottmann M, Flesken-Nikitin A, Ellenson LH, Kirchner T, Mayr D, Nikitin AY.

Mod Pathol. 2017 Sep;30(9):1241-1250. doi: 10.1038/modpathol.2017.53. Epub 2017 Jun 30.

9.

Interobserver Reproducibility Among Gynecologic Pathologists in Diagnosing Heterologous Osteosarcomatous Component in Gynecologic Tract Carcinosarcomas.

Sangoi AR, Kshirsagar M, Roma AA, Horvai AE, Chivukula M, Ellenson LH, Fadare O, Folkins AK, Garg K, Hanley K, Longacre TA, Haas J, McCluggage WG, McKenney JK, Nucci MR, Oliva E, Park KJ, Parkash V, Quick CM, Rabban JT, Rutgers JKL, Soslow R, Vang R, Yemelyanova A, Zaloudek C, Beck AH.

Int J Gynecol Pathol. 2017 Jul;36(4):386-392. doi: 10.1097/PGP.0000000000000329.

PMID:
28221217
10.

PI3K/PTEN/AKT Genetic Mouse Models of Endometrial Carcinoma.

Joshi A, Ellenson LH.

Adv Exp Med Biol. 2017;943:261-273.

PMID:
27910071
11.

Does the Presence of Endometriosis Affect Prognosis of Ovarian Cancer?

Dinkelspiel HE, Matrai C, Pauk S, Pierre-Louis A, Chiu YL, Gupta D, Caputo T, Ellenson LH, Holcomb K.

Cancer Invest. 2016;34(3):148-54. doi: 10.3109/07357907.2016.1139716. Epub 2016 Mar 17.

12.

Clinically aggressive "low-grade" uterine carcinosarcoma: A case report.

Clearman T, Cimic A, Ellenson LH, Gupta D.

Gynecol Oncol Rep. 2015 Aug 20;14:9-11. doi: 10.1016/j.gore.2015.08.002. eCollection 2015 Nov.

13.

ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis.

Cubillos-Ruiz JR, Silberman PC, Rutkowski MR, Chopra S, Perales-Puchalt A, Song M, Zhang S, Bettigole SE, Gupta D, Holcomb K, Ellenson LH, Caputo T, Lee AH, Conejo-Garcia JR, Glimcher LH.

Cell. 2015 Jun 18;161(7):1527-38. doi: 10.1016/j.cell.2015.05.025. Epub 2015 Jun 11.

14.

A New Historical Feature for the Journal: Eponyms and Entities.

Ellenson LH, Young RH.

Int J Gynecol Pathol. 2015 Jul;34(4):313. doi: 10.1097/PGP.0000000000000224. No abstract available.

PMID:
26061069
15.

Activated mutant p110α causes endometrial carcinoma in the setting of biallelic Pten deletion.

Joshi A, Miller C Jr, Baker SJ, Ellenson LH.

Am J Pathol. 2015 Apr;185(4):1104-13. doi: 10.1016/j.ajpath.2014.12.019. Epub 2015 Feb 16.

16.

Letter from the editor.

Ellenson LH.

Int J Gynecol Pathol. 2015 Mar;34(2):111. doi: 10.1097/PGP.0000000000000201. No abstract available.

PMID:
25675177
17.

Molecular alterations of PIK3CA in uterine carcinosarcoma, clear cell, and serous tumors.

Bashir S, Jiang G, Joshi A, Miller C Jr, Matrai C, Yemelyanova A, Caputo TA, Holcomb KM, Ellenson LH, Gupta D.

Int J Gynecol Cancer. 2014 Sep;24(7):1262-7. doi: 10.1097/IGC.0000000000000183.

PMID:
25078343
18.

Mammalian target of rapamycin complex 1 and cyclooxygenase 2 pathways cooperatively exacerbate endometrial cancer.

Daikoku T, Terakawa J, Hossain MM, Yoshie M, Cappelletti M, Yang P, Ellenson LH, Dey SK.

Am J Pathol. 2014 Sep;184(9):2390-402. doi: 10.1016/j.ajpath.2014.05.023. Epub 2014 Jul 21.

19.

Conditional deletion of Tsc1 in the female reproductive tract impedes normal oviductal and uterine function by enhancing mTORC1 signaling in mice.

Daikoku T, Yoshie M, Xie H, Sun X, Cha J, Ellenson LH, Dey SK.

Mol Hum Reprod. 2013 Jul;19(7):463-72. doi: 10.1093/molehr/gat016. Epub 2013 Mar 7.

20.

ProNGF, a cytokine induced after myocardial infarction in humans, targets pericytes to promote microvascular damage and activation.

Siao CJ, Lorentz CU, Kermani P, Marinic T, Carter J, McGrath K, Padow VA, Mark W, Falcone DJ, Cohen-Gould L, Parrish DC, Habecker BA, Nykjaer A, Ellenson LH, Tessarollo L, Hempstead BL.

J Exp Med. 2012 Nov 19;209(12):2291-305. doi: 10.1084/jem.20111749. Epub 2012 Oct 22.

21.

Does the presence of adenomyosis and lymphovascular space invasion affect lymph node status in patients with endometrioid adenocarcinoma of the endometrium?

Musa F, Frey MK, Im HB, Chekmareva M, Ellenson LH, Holcomb K.

Am J Obstet Gynecol. 2012 Nov;207(5):417.e1-6. doi: 10.1016/j.ajog.2012.06.051. Epub 2012 Jun 29.

PMID:
22840974
22.

Endometrial tumorigenesis in Pten(+/-) mice is independent of coexistence of estrogen and estrogen receptor α.

Joshi A, Wang H, Jiang G, Douglas W, Chan JS, Korach KS, Ellenson LH.

Am J Pathol. 2012 Jun;180(6):2536-47. doi: 10.1016/j.ajpath.2012.03.006. Epub 2012 Apr 13.

23.

Cell-specific conditional deletion of Pten in the uterus results in differential phenotypes.

Daikoku T, Jackson L, Besnard V, Whitsett J, Ellenson LH, Dey SK.

Gynecol Oncol. 2011 Aug;122(2):424-9. doi: 10.1016/j.ygyno.2011.04.022. Epub 2011 May 13.

24.

Adenovirus mediated homozygous endometrial epithelial Pten deletion results in aggressive endometrial carcinoma.

Joshi A, Ellenson LH.

Exp Cell Res. 2011 Jul 1;317(11):1580-9. doi: 10.1016/j.yexcr.2011.03.006. Epub 2011 Mar 21.

25.

Strategies for high-resolution imaging of epithelial ovarian cancer by laparoscopic nonlinear microscopy.

Williams RM, Flesken-Nikitin A, Ellenson LH, Connolly DC, Hamilton TC, Nikitin AY, Zipfel WR.

Transl Oncol. 2010 Jun 1;3(3):181-94.

26.

Frequent downregulation of miR-34 family in human ovarian cancers.

Corney DC, Hwang CI, Matoso A, Vogt M, Flesken-Nikitin A, Godwin AK, Kamat AA, Sood AK, Ellenson LH, Hermeking H, Nikitin AY.

Clin Cancer Res. 2010 Feb 15;16(4):1119-28. doi: 10.1158/1078-0432.CCR-09-2642. Epub 2010 Feb 9.

27.

Molecular alterations in uterine serous carcinoma.

Hayes MP, Ellenson LH.

Gynecol Oncol. 2010 Feb;116(2):286-9. doi: 10.1016/j.ygyno.2009.11.012. Review.

PMID:
20109727
28.

Induction of ovarian leiomyosarcomas in mice by conditional inactivation of Brca1 and p53.

Quinn BA, Brake T, Hua X, Baxter-Jones K, Litwin S, Ellenson LH, Connolly DC.

PLoS One. 2009 Dec 31;4(12):e8404. doi: 10.1371/journal.pone.0008404.

29.

Molecular alterations of EGFR and PIK3CA in uterine serous carcinoma.

Hayes MP, Douglas W, Ellenson LH.

Gynecol Oncol. 2009 Jun;113(3):370-3. doi: 10.1016/j.ygyno.2008.12.021. Epub 2009 Mar 9.

30.

Oviduct-specific glycoprotein is a molecular marker for invasion in endometrial tumorigenesis identified using a relevant mouse model.

Wang H, Joshi A, Iaconis L, Solomon GJ, Xiang Z, Verhage HG, Douglas W, Ronnett BM, Ellenson LH.

Int J Cancer. 2009 Mar 15;124(6):1349-57. doi: 10.1002/ijc.24022.

31.

Immunoprofile of adenocarcinomas of the endometrium, endocervix, and ovary with mucinous differentiation.

Park KJ, Bramlage MP, Ellenson LH, Pirog EC.

Appl Immunohistochem Mol Morphol. 2009 Jan;17(1):8-11. doi: 10.1097/PAI.0b013e318174f012.

PMID:
18776815
32.

Immunohistochemical differences between mucinous and microglandular adenocarcinomas of the endometrium and benign endocervical epithelium.

Chekmareva M, Ellenson LH, Pirog EC.

Int J Gynecol Pathol. 2008 Oct;27(4):547-54. doi: 10.1097/PGP.0b013e318177eadc.

PMID:
18753965
33.

Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice.

Daikoku T, Hirota Y, Tranguch S, Joshi AR, DeMayo FJ, Lydon JP, Ellenson LH, Dey SK.

Cancer Res. 2008 Jul 15;68(14):5619-27. doi: 10.1158/0008-5472.CAN-08-1274.

34.

Primary chemoprevention of endometrial hyperplasia with the peroxisome proliferator-activated receptor gamma agonist rosiglitazone in the PTEN heterozygote murine model.

Wu W, Celestino J, Milam MR, Schmeler KM, Broaddus RR, Ellenson LH, Lu KH.

Int J Gynecol Cancer. 2008 Mar-Apr;18(2):329-38. doi: 10.1111/j.1525-1438.2007.01002.x.

PMID:
18334011
35.

Endometrial carcinoma.

Di Cristofano A, Ellenson LH.

Annu Rev Pathol. 2007;2:57-85. Review.

PMID:
18039093
36.
37.

p16 and Ki-67 immunostaining in atypical immature squamous metaplasia of the uterine cervix: correlation with human papillomavirus detection.

Iaconis L, Hyjek E, Ellenson LH, Pirog EC.

Arch Pathol Lab Med. 2007 Sep;131(9):1343-9. Erratum in: Arch Pathol Lab Med. 2008 Jan;132(1):13.

PMID:
17824788
38.

The high-mobility group A1 gene up-regulates cyclooxygenase 2 expression in uterine tumorigenesis.

Tesfaye A, Di Cello F, Hillion J, Ronnett BM, Elbahloul O, Ashfaq R, Dhara S, Prochownik E, Tworkoski K, Reeves R, Roden R, Ellenson LH, Huso DL, Resar LM.

Cancer Res. 2007 May 1;67(9):3998-4004.

39.

Reduced progression of endometrial hyperplasia with oral mTOR inhibition in the Pten heterozygote murine model.

Milam MR, Celestino J, Wu W, Broaddus RR, Schmeler KM, Slomovitz BM, Soliman PT, Gershenson DM, Wang H, Ellenson LH, Lu KH.

Am J Obstet Gynecol. 2007 Mar;196(3):247.e1-5.

PMID:
17346540
40.

PIK3CA and PTEN mutations in uterine endometrioid carcinoma and complex atypical hyperplasia.

Hayes MP, Wang H, Espinal-Witter R, Douglas W, Solomon GJ, Baker SJ, Ellenson LH.

Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):5932-5.

41.

Akt-mediated phosphorylation and activation of estrogen receptor alpha is required for endometrial neoplastic transformation in Pten+/- mice.

Vilgelm A, Lian Z, Wang H, Beauparlant SL, Klein-Szanto A, Ellenson LH, Di Cristofano A.

Cancer Res. 2006 Apr 1;66(7):3375-80.

42.
43.

Histologic type, organ of origin, and Wnt pathway status: effect on gene expression in ovarian and uterine carcinomas.

Shedden KA, Kshirsagar MP, Schwartz DR, Wu R, Yu H, Misek DE, Hanash S, Katabuchi H, Ellenson LH, Fearon ER, Cho KR.

Clin Cancer Res. 2005 Mar 15;11(6):2123-31.

44.

Molecular genetic characterization of tamoxifen-associated endometrial cancer.

Prasad M, Wang H, Douglas W, Barakat RR, Ellenson LH.

Gynecol Oncol. 2005 Jan;96(1):25-31.

PMID:
15589576
45.

Current challenges and opportunities for research on borderline ovarian tumors.

Sherman ME, Berman J, Birrer MJ, Cho KR, Ellenson LH, Gorstein F, Seidman JD.

Hum Pathol. 2004 Aug;35(8):961-70.

PMID:
15297963
46.

Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: workshop perspectives.

Bell DA, Longacre TA, Prat J, Kohn EC, Soslow RA, Ellenson LH, Malpica A, Stoler MH, Kurman RJ.

Hum Pathol. 2004 Aug;35(8):934-48.

PMID:
15297961
47.

Focus on endometrial and cervical cancer.

Ellenson LH, Wu TC.

Cancer Cell. 2004 Jun;5(6):533-8. Review. No abstract available.

48.

Molecular characterization of uterine clear cell carcinoma.

An HJ, Logani S, Isacson C, Ellenson LH.

Mod Pathol. 2004 May;17(5):530-7.

50.

Amplification and overexpression of the L-MYC proto-oncogene in ovarian carcinomas.

Wu R, Lin L, Beer DG, Ellenson LH, Lamb BJ, Rouillard JM, Kuick R, Hanash S, Schwartz DR, Fearon ER, Cho KR.

Am J Pathol. 2003 May;162(5):1603-10.

Supplemental Content

Loading ...
Support Center